Triagenics Inc.

04/29/2026 | Press release | Distributed by Public on 04/29/2026 08:59

Annual Report by Private Issuer (Form C-AR)

FORM C UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
OMB APPROVAL


FORM C-AR

OMB Number: ####-####

Estimated average burden hours per response: ##.#

Form C: Filer Information

Filer CIK:
0001732710
Filer CCC:
XXXXXXXX
Period:
09-30-2025


Is this a LIVE or TEST Filing? LIVE TEST
Is this an electronic copy of an official filing submitted in paper format in connection with a hardship exemption?
Would you like a Return Copy?

Submission Contact Information

Name:
Phone Number:
Contact E-Mail Address:
Notify via Filing Website only?

Form C: Issuer Information

Issuer Information

Name of Issuer:
TriAgenics, Inc


Legal Status of Issuer:

Form:
Corporation


Jurisdiction of Incorporation/Organization:
DELAWARE


Date of Incorporation/Organization:
09-22-2017


Physical Address of Issuer:

Address 1:
525 SW UMATILLA AVE


Address 2:
SUITE 102


City:
REDMOND


State/Country:
OREGON


Mailing Zip/Postal Code:
97656


Website of Issuer:
www.TriAgenics.com


Form C: Annual Report Disclosure Requirements

Annual Report Disclosure Requirements

Current Number of Employees:
3.00


Total Assets Most Recent Fiscal Year-end:
3246152.00


Total Assets Prior Fiscal Year-end:
1290005.00


Cash and Cash Equivalents Most Recent Fiscal Year-end:
3045890.00


Cash and Cash Equivalents Prior Fiscal Year-end:
976252.00


Accounts Receivable Most Recent Fiscal Year-end:
0.00


Accounts Receivable Prior Fiscal Year-end:
0.00


Short-term Debt Most Recent Fiscal Year-end:
160614.00


Short-term Debt Prior Fiscal Year-end:
159014.00


Long-term Debt Most Recent Fiscal Year-end:
0.00


Long-term Debt Prior Fiscal Year-end:
0.00


Revenue/Sales Most Recent Fiscal Year-end:
0.00


Revenue/Sales Prior Fiscal Year-end:
0.00


Cost of Goods Sold Most Recent Fiscal Year-end:
0.00


Cost of Goods Sold Prior Fiscal Year-end:
0.00


Taxes Paid Most Recent Fiscal Year-end:
-410.00


Taxes Paid Prior Fiscal Year-end:
2433.00


Net Income Most Recent Fiscal Year-end:
-2242946.00


Net Income Prior Fiscal Year-end:
-2183070.00


Form C: Signature

Signature

Pursuant to the requirements of Sections 4(a)(6) and 4A of the Securities Act of 1933 and Regulation Crowdfunding (§ 227.100-503), the issuer certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form C and has duly caused this Form to be signed on its behalf by the duly authorized undersigned.
Issuer:
TriAgenics, Inc


Signature:
David Thrower


Title:
Chief Executive Officer


Pursuant to the requirements of Sections 4(a)(6) and 4A of the Securities Act of 1933 and Regulation Crowdfunding (§ 227.100-503), this Form C has been signed by the following persons in the capacities and on the dates indicated.

Signature:
Leigh Colby


Title:
Director


Date:
04-29-2026


Pursuant to the requirements of Sections 4(a)(6) and 4A of the Securities Act of 1933 and Regulation Crowdfunding (§ 227.100-503), this Form C has been signed by the following persons in the capacities and on the dates indicated.

Signature:
David Thrower


Title:
Director


Date:
04-29-2026


Pursuant to the requirements of Sections 4(a)(6) and 4A of the Securities Act of 1933 and Regulation Crowdfunding (§ 227.100-503), this Form C has been signed by the following persons in the capacities and on the dates indicated.

Signature:
Dave Watson


Title:
Director


Date:
04-29-2026


Pursuant to the requirements of Sections 4(a)(6) and 4A of the Securities Act of 1933 and Regulation Crowdfunding (§ 227.100-503), this Form C has been signed by the following persons in the capacities and on the dates indicated.

Signature:
John Joseph Chopack, Jr


Title:
Director


Date:
04-29-2026


Pursuant to the requirements of Sections 4(a)(6) and 4A of the Securities Act of 1933 and Regulation Crowdfunding (§ 227.100-503), this Form C has been signed by the following persons in the capacities and on the dates indicated.

Signature:
Jeffrey Miles Jacobs


Title:
Director


Date:
04-29-2026


Pursuant to the requirements of Sections 4(a)(6) and 4A of the Securities Act of 1933 and Regulation Crowdfunding (§ 227.100-503), this Form C has been signed by the following persons in the capacities and on the dates indicated.

Signature:
David Jahns


Title:
Director


Date:
04-29-2026


Triagenics Inc. published this content on April 29, 2026, and is solely responsible for the information contained herein. Distributed via EDGAR on April 29, 2026 at 14:59 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]